This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Loryna 3 mg-0.02 mg tablet, 28s, a prescription medication, with an ultimate completion date of April 16, 2025 and a ceiling value of $2,250.96. The contract is not set-aside and is awarded under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,033.52, is for the delivery of the prescription medication Loryna 3 mg-0.02 mg tablet in 28 count packages. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen holds a substantial Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,232.44 firm fixed-price contract is for the pharmaceutical product LORYNA 3 MG-0.02 MG TABLET 28S, to be delivered by February 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LORYNA 3 MG-0.02 MG TABLET 28S, a pharmaceutical product, with a ceiling value of $4,812.87 and a performance period ending on May 12, 2025. The contract is a firm fixed-price, non-set-aside delivery order, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of the pharmaceutical product Loryna 3 mg-0.02 mg tablet, with a ceiling value of $2,220.57 and a performance period through April 16, 2025. The contract is not set aside and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime contractor....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,378.00, is a delivery order for the medication Loryna 3 mg-0.02 mg tablet 28s. The contract is a firm fixed-price arrangement without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,641.63, is for the delivery of the drug Loryna 3 mg-0.02 mg tablet in quantities of 28 tablets. The contract is a Firm Fixed Price Delivery Order, with a completion date of November 27, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,101.41 firm fixed-price delivery order is for the supply of the prescription medication Loryna 3 mg-0.02 mg tablets. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product Loryna 3 mg-0.02 mg tablet, 28-count. The contract has a total ceiling value of $2,057.63 and a period of performance ending on August 2, 2024. The contract is a firm-fixed price type with no set-aside designation. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, will deliver the...
This is a federal contract award from the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $1,150.77, is a delivery order for the pharmaceutical product LORYNA 3 MG-0.02 MG Tablet 28S. The contract has an ultimate completion date of December 10, 2024. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in...